NL8900383A - Nieuwe cosmetische samenstellingen die dienen voor het bestrijden van cellulitis. - Google Patents

Nieuwe cosmetische samenstellingen die dienen voor het bestrijden van cellulitis. Download PDF

Info

Publication number: NL8900383A
Authority: NL; Netherlands
Prior art keywords: cosmetic compositions; contain; extract; compositions according; skin
Prior art date: 1988-02-18

Application number

NL8900383A

Other languages

English (en)

Dutch (nl)

Original Assignee

Roussel Uclaf

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1988-02-18

Filing date

1989-02-16

Publication date

1989-09-18

1989-02-16 Application filed by Roussel Uclaf filed Critical Roussel Uclaf

1989-09-18 Publication of NL8900383A publication Critical patent/NL8900383A/nl

Links

239000000203 mixture Substances 0.000 title claims description 41
239000002537 cosmetic Substances 0.000 title claims description 32
206010007882 Cellulitis Diseases 0.000 title 1
239000000284 extract Substances 0.000 claims description 23
229920002683 Glycosaminoglycan Polymers 0.000 claims description 19
RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 claims description 12
208000035484 Cellulite Diseases 0.000 claims description 11
206010049752 Peau d'orange Diseases 0.000 claims description 11
230000036232 cellulite Effects 0.000 claims description 11
241001465754 Metazoa Species 0.000 claims description 7
210000002808 connective tissue Anatomy 0.000 claims description 7
LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 claims description 6
229960001948 caffeine Drugs 0.000 claims description 6
VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 claims description 6
239000002502 liposome Substances 0.000 claims description 6
238000000034 method Methods 0.000 claims description 6
239000002253 acid Substances 0.000 claims description 5
239000006071 cream Substances 0.000 claims description 5
150000007513 acids Chemical class 0.000 claims description 4
210000001198 duodenum Anatomy 0.000 claims 2
241000282887 Suidae Species 0.000 claims 1
239000011230 binding agent Substances 0.000 claims 1
239000000499 gel Substances 0.000 description 8
239000003925 fat Substances 0.000 description 7
-1 chondroitin sulfuric acids Chemical class 0.000 description 6
230000004130 lipolysis Effects 0.000 description 6
230000004936 stimulating effect Effects 0.000 description 6
102000004882 Lipase Human genes 0.000 description 5
108090001060 Lipase Proteins 0.000 description 5
239000004367 Lipase Substances 0.000 description 5
235000019421 lipase Nutrition 0.000 description 5
239000000523 sample Substances 0.000 description 5
210000001519 tissue Anatomy 0.000 description 5
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
235000014113 dietary fatty acids Nutrition 0.000 description 4
239000000194 fatty acid Substances 0.000 description 4
229930195729 fatty acid Natural products 0.000 description 4
102000008186 Collagen Human genes 0.000 description 3
108010035532 Collagen Proteins 0.000 description 3
IVOMOUWHDPKRLL-KQYNXXCUSA-N Cyclic adenosine monophosphate Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-KQYNXXCUSA-N 0.000 description 3
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
IVOMOUWHDPKRLL-UHFFFAOYSA-N UNPD107823 Natural products O1C2COP(O)(=O)OC2C(O)C1N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-UHFFFAOYSA-N 0.000 description 3
210000000577 adipose tissue Anatomy 0.000 description 3
239000000969 carrier Substances 0.000 description 3
229920001436 collagen Polymers 0.000 description 3
229940095074 cyclic amp Drugs 0.000 description 3
210000004177 elastic tissue Anatomy 0.000 description 3
229920005862 polyol Polymers 0.000 description 3
150000003077 polyols Chemical class 0.000 description 3
239000003755 preservative agent Substances 0.000 description 3
239000008213 purified water Substances 0.000 description 3
VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
208000034189 Sclerosis Diseases 0.000 description 2
229920002125 Sokalan® Polymers 0.000 description 2
HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 2
OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
210000001789 adipocyte Anatomy 0.000 description 2
125000003118 aryl group Chemical group 0.000 description 2
230000015572 biosynthetic process Effects 0.000 description 2
210000001217 buttock Anatomy 0.000 description 2
229940098366 cola extract Drugs 0.000 description 2
239000006260 foam Substances 0.000 description 2
BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
230000004089 microcirculation Effects 0.000 description 2
235000013336 milk Nutrition 0.000 description 2
239000008267 milk Substances 0.000 description 2
210000004080 milk Anatomy 0.000 description 2
239000004033 plastic Substances 0.000 description 2
229920003023 plastic Polymers 0.000 description 2
229920000642 polymer Polymers 0.000 description 2
239000001587 sorbitan monostearate Substances 0.000 description 2
229940035048 sorbitan monostearate Drugs 0.000 description 2
235000011076 sorbitan monostearate Nutrition 0.000 description 2
239000000126 substance Substances 0.000 description 2
238000003786 synthesis reaction Methods 0.000 description 2
YAPQBXQYLJRXSA-UHFFFAOYSA-N theobromine Chemical compound CN1C(=O)NC(=O)C2=C1N=CN2C YAPQBXQYLJRXSA-UHFFFAOYSA-N 0.000 description 2
ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 2
150000003626 triacylglycerols Chemical class 0.000 description 2
238000002604 ultrasonography Methods 0.000 description 2
210000000689 upper leg Anatomy 0.000 description 2
KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
244000291564 Allium cepa Species 0.000 description 1
235000002732 Allium cepa var. cepa Nutrition 0.000 description 1
239000002126 C01EB10 - Adenosine Substances 0.000 description 1
229920002567 Chondroitin Polymers 0.000 description 1
241000195493 Cryptophyta Species 0.000 description 1
102000004190 Enzymes Human genes 0.000 description 1
108090000790 Enzymes Proteins 0.000 description 1
235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
206010020843 Hyperthermia Diseases 0.000 description 1
229920000288 Keratan sulfate Polymers 0.000 description 1
239000004166 Lanolin Substances 0.000 description 1
102000004895 Lipoproteins Human genes 0.000 description 1
108090001030 Lipoproteins Proteins 0.000 description 1
241000909578 Nectandra Species 0.000 description 1
239000004264 Petrolatum Substances 0.000 description 1
102000004861 Phosphoric Diester Hydrolases Human genes 0.000 description 1
108090001050 Phosphoric Diester Hydrolases Proteins 0.000 description 1
239000004698 Polyethylene Substances 0.000 description 1
238000000692 Student's t-test Methods 0.000 description 1
240000000851 Vaccinium corymbosum Species 0.000 description 1
235000003095 Vaccinium corymbosum Nutrition 0.000 description 1
235000017537 Vaccinium myrtillus Nutrition 0.000 description 1
230000001133 acceleration Effects 0.000 description 1
230000035508 accumulation Effects 0.000 description 1
238000009825 accumulation Methods 0.000 description 1
230000003213 activating effect Effects 0.000 description 1
230000004913 activation Effects 0.000 description 1
229960005305 adenosine Drugs 0.000 description 1
210000001557 animal structure Anatomy 0.000 description 1
235000021014 blueberries Nutrition 0.000 description 1
210000000845 cartilage Anatomy 0.000 description 1
230000015556 catabolic process Effects 0.000 description 1
210000000170 cell membrane Anatomy 0.000 description 1
229960000541 cetyl alcohol Drugs 0.000 description 1
239000000571 coke Substances 0.000 description 1
238000006731 degradation reaction Methods 0.000 description 1
230000018044 dehydration Effects 0.000 description 1
238000006297 dehydration reaction Methods 0.000 description 1
230000008021 deposition Effects 0.000 description 1
206010012601 diabetes mellitus Diseases 0.000 description 1
235000005911 diet Nutrition 0.000 description 1
230000000378 dietary effect Effects 0.000 description 1
229940031766 diethanolamine cetyl phosphate Drugs 0.000 description 1
238000006073 displacement reaction Methods 0.000 description 1
230000005489 elastic deformation Effects 0.000 description 1
239000003995 emulsifying agent Substances 0.000 description 1
239000000839 emulsion Substances 0.000 description 1
230000002255 enzymatic effect Effects 0.000 description 1
150000002148 esters Chemical class 0.000 description 1
239000004744 fabric Substances 0.000 description 1
150000004665 fatty acids Chemical class 0.000 description 1
230000002068 genetic effect Effects 0.000 description 1
239000011521 glass Substances 0.000 description 1
ZUVCYFMOHFTGDM-UHFFFAOYSA-N hexadecyl dihydrogen phosphate Chemical compound CCCCCCCCCCCCCCCCOP(O)(O)=O ZUVCYFMOHFTGDM-UHFFFAOYSA-N 0.000 description 1
GKKMCECQQIKAHA-UHFFFAOYSA-N hexadecyl dihydrogen phosphate;2-(2-hydroxyethylamino)ethanol Chemical compound OCCNCCO.CCCCCCCCCCCCCCCCOP(O)(O)=O GKKMCECQQIKAHA-UHFFFAOYSA-N 0.000 description 1
230000003054 hormonal effect Effects 0.000 description 1
229920002674 hyaluronan Polymers 0.000 description 1
229960003160 hyaluronic acid Drugs 0.000 description 1
230000007062 hydrolysis Effects 0.000 description 1
238000006460 hydrolysis reaction Methods 0.000 description 1
WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
230000036031 hyperthermia Effects 0.000 description 1
230000002401 inhibitory effect Effects 0.000 description 1
KXCLCNHUUKTANI-RBIYJLQWSA-N keratan Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@H](COS(O)(=O)=O)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@H](O[C@@H](O[C@H]3[C@H]([C@@H](COS(O)(=O)=O)O[C@@H](O)[C@@H]3O)O)[C@H](NC(C)=O)[C@H]2O)COS(O)(=O)=O)O[C@H](COS(O)(=O)=O)[C@@H]1O KXCLCNHUUKTANI-RBIYJLQWSA-N 0.000 description 1
210000003127 knee Anatomy 0.000 description 1
229940039717 lanolin Drugs 0.000 description 1
235000019388 lanolin Nutrition 0.000 description 1
230000037356 lipid metabolism Effects 0.000 description 1
150000002632 lipids Chemical group 0.000 description 1
230000002366 lipolytic effect Effects 0.000 description 1
239000006210 lotion Substances 0.000 description 1
230000007257 malfunction Effects 0.000 description 1
238000005259 measurement Methods 0.000 description 1
238000000691 measurement method Methods 0.000 description 1
230000003020 moisturizing effect Effects 0.000 description 1
210000003205 muscle Anatomy 0.000 description 1
125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
229940066842 petrolatum Drugs 0.000 description 1
235000019271 petrolatum Nutrition 0.000 description 1
239000000546 pharmaceutical excipient Substances 0.000 description 1
229920000573 polyethylene Polymers 0.000 description 1
229940051841 polyoxyethylene ether Drugs 0.000 description 1
229920000056 polyoxyethylene ether Polymers 0.000 description 1
238000002360 preparation method Methods 0.000 description 1
230000001737 promoting effect Effects 0.000 description 1
102000004169 proteins and genes Human genes 0.000 description 1
108090000623 proteins and genes Proteins 0.000 description 1
230000001172 regenerating effect Effects 0.000 description 1
230000008929 regeneration Effects 0.000 description 1
238000011069 regeneration method Methods 0.000 description 1
239000003381 stabilizer Substances 0.000 description 1
238000000528 statistical test Methods 0.000 description 1
238000005728 strengthening Methods 0.000 description 1
238000007920 subcutaneous administration Methods 0.000 description 1
229960004559 theobromine Drugs 0.000 description 1
229960000278 theophylline Drugs 0.000 description 1
239000002562 thickening agent Substances 0.000 description 1
230000000699 topical effect Effects 0.000 description 1
239000000080 wetting agent Substances 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/14—Liposomes; Vesicles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/981—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/06—Preparations for care of the skin for countering cellulitis

Landscapes

Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Birds (AREA)
Mycology (AREA)
Microbiology (AREA)
Botany (AREA)
Biotechnology (AREA)
Engineering & Computer Science (AREA)
Dermatology (AREA)
Zoology (AREA)
Cosmetics (AREA)

NL8900383A 1988-02-18 1989-02-16 Nieuwe cosmetische samenstellingen die dienen voor het bestrijden van cellulitis. NL8900383A (nl)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR8801927A FR2627388B1 (fr)	1988-02-18	1988-02-18	Nouvelles compositions cosmetiques destinees a combattre la cellulite
FR8801927		1988-02-18

Publications (1)

Publication Number	Publication Date
NL8900383A true NL8900383A (nl)	1989-09-18

Family

ID=9363371

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NL8900383A NL8900383A (nl)	1988-02-18	1989-02-16	Nieuwe cosmetische samenstellingen die dienen voor het bestrijden van cellulitis.

Country Status (6)

Country	Link
BE (1)	BE1005177A4 (it)
CH (1)	CH678011A5 (it)
DE (1)	DE3905167A1 (it)
FR (1)	FR2627388B1 (it)
IT (1)	IT1230480B (it)
NL (1)	NL8900383A (it)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2732216A1 (fr) *	1995-03-30	1996-10-04	G2R Groupe Rech Realites	Procede de traitement esthetique d'un etre humain presentant notamment des marques de cellulite et substance pour sa mise en oeuvre
GB9902527D0 (en)	1999-02-04	1999-03-24	Phares Pharm Res Nv	Compositions
DE19904907C2 (de) *	1999-02-06	2003-03-27	Rudolf Weyergans	Verfahren zur lokalen Verminderung von Fett- und Stoffwechselschlackenaufspeicherungen zur Verbesserung der körperlichen Erscheinung bei Cellulite
EP1987812A1 (de) *	2007-04-23	2008-11-05	Fibona Health Products GmbH	Tagesrhytmisch angepasste Anwendung von Hyaferm bei Cellulite
US9572880B2 (en)	2010-08-27	2017-02-21	Sienna Biopharmaceuticals, Inc.	Ultrasound delivery of nanoparticles
HUE038539T2 (hu)	2010-08-27	2018-10-29	Sienna Biopharmaceuticals Inc	Készítmények eljárások célzott hõmodulációhoz
JP6325552B2 (ja)	2012-10-11	2018-05-16	ナノコンポジックス，インコーポレイテッド	銀ナノプレート組成物および方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IT1044756B (it) *	1967-09-14	1980-04-21	Prephar	Preparazione cosmetiche ad uso percutameo a base di sostanze naturali denominate glucidamine
DE2364373A1 (de) *	1973-12-22	1975-07-10	Hahn Carl Dr Gmbh	Pharmazeutische und kosmetische praeparate zur aeusserlichen anwendung
FR2362632A1 (fr) *	1976-08-23	1978-03-24	Moreau Monique	Nouvelles preparations pour le traitement des manifestations corporelles inesthetiques et procede de traitement
IT1209301B (it) *	1980-01-22	1989-07-16	Sergio Bertini Curri	Utilizzazione di precursori biochimici dei glucosaminglicani.
FR2554344B1 (fr) *	1983-11-07	1986-09-05	Pf Cosmetique	Composition cosmetique a action amincissante et anti-cellulitique
FR2556217A1 (fr) *	1983-12-09	1985-06-14	Biosculpture	Compositions cosmetiques anti-surcharges graisseuses et application sur le corps humain par ionophorese

1988
- 1988-02-18 FR FR8801927A patent/FR2627388B1/fr not_active Expired - Fee Related
1989
- 1989-02-16 NL NL8900383A patent/NL8900383A/nl not_active Application Discontinuation
- 1989-02-17 IT IT8947667A patent/IT1230480B/it active
- 1989-02-17 BE BE8900163A patent/BE1005177A4/fr not_active IP Right Cessation
- 1989-02-17 CH CH561/89A patent/CH678011A5/fr not_active IP Right Cessation
- 1989-02-20 DE DE3905167A patent/DE3905167A1/de not_active Withdrawn

Also Published As

Publication number	Publication date
DE3905167A1 (de)	1989-08-31
IT1230480B (it)	1991-10-24
FR2627388B1 (fr)	1991-06-14
FR2627388A1 (fr)	1989-08-25
CH678011A5 (it)	1991-07-31
BE1005177A4 (fr)	1993-05-18
IT8947667A0 (it)	1989-02-17

Legal Events

Date	Code	Title
1994-10-03	BV	The patent application has lapsed
1996-06-03	BB	A search report has been drawn up
1996-12-02	BV	The patent application has lapsed

Publication	Publication Date	Title
ES2265884T3 (es)	2007-03-01	Utilizacion como agente tensor de al menos un polimero siliconado injertado.
US20210121379A1 (en)	2021-04-29	Composition comprising at least two fatty acid esters of (poly)glycerol, and use thereof in cosmetics
US20080275118A1 (en)	2008-11-06	Health and cosmetic composition and regime for stimulating hair growth and thickening on the head, including the scalp, eyelashes, and eyebrows, and which discourages hair loss
US20080183250A1 (en)	2008-07-31	Compositions and methods for treating or preventing skin inflammation via restoration of skin barrier function
US20080153839A1 (en)	2008-06-26	Use of anisic acid for promoting desquamation
ES2617262T3 (es)	2017-06-16	Composición cosmética y farmacéutica que comprende 6-fosfato de N-acetilglucosamina y un compuesto de la familia de la vitamina A
JP2010155836A (ja)	2010-07-15	単糖とｃ−グリコシド誘導体との組合せ及びその美容的使用
CN110051614A (zh)	2019-07-26	一种抗皱嫩肤精华
US20120114689A1 (en)	2012-05-10	Nicotinamide compositions for treatment of skin diseases and disorders
JP2011525495A (ja)	2011-09-22	ヒトデ体液を含んでなる化粧組成物及びその使用方法。
TWI324932B (en)	2010-05-21	Sugar-uptake promoting agent
KR101667082B1 (ko)	2016-10-17	사람의 피부를 위한 “볼륨화” 및/또는 “볼록화”제로서 이소류신 ｎ-헥사데카노일의 용도
AU696398B2 (en)	1998-09-10	Cosmetic composition containing hydroxy alkanoate derivatives
CN105263583B (zh)	2020-11-24	圆穗蓼提取物的化妆品用途或皮肤病用途
EP3228305B1 (en)	2020-01-01	Topical compositions containing cross-linked glycosaminoglycans
JP2919973B2 (ja)	1999-07-19	アルカノアートをコンディショナーとして含有するクレンジング組成物
JPH06104620B2 (ja)	1994-12-21	皮膚化粧料
BE1005177A4 (fr)	1993-05-18	Nouvelles compositions cosmetiques destinees a combattre la cellulite.
WO2014180808A1 (en)	2014-11-13	Use of petroselinic acid for combating aesthetic disorders of the figure associated with adipose tissue modifications
JP2018145106A (ja)	2018-09-20	皮膚外用組成物
JPH0696514B2 (ja)	1994-11-30	皮膚化粧料
WO2002020622A1 (en)	2002-03-14	A mixture of non-sulfated fucose-based oligosaccharides, a cosmetic or pharmaceutical composition comprising said mixture and its use in cosmetics or pharmacy
JPH09255546A (ja)	1997-09-30	皮膚外用剤
JP2009256269A (ja)	2009-11-05	プロフィラグリン及び／又はフィラグリン産生促進剤
JP2003192525A (ja)	2003-07-09	疑似生体性ポリマー及びスフィンゴシン類似物質を含有する皮膚外用剤